1. Home
  2. COHU vs MLYS Comparison

COHU vs MLYS Comparison

Compare COHU & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHU
  • MLYS
  • Stock Information
  • Founded
  • COHU 1947
  • MLYS 2019
  • Country
  • COHU United States
  • MLYS United States
  • Employees
  • COHU N/A
  • MLYS N/A
  • Industry
  • COHU Electrical Products
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • COHU Industrials
  • MLYS Health Care
  • Exchange
  • COHU Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • COHU 894.7M
  • MLYS 1.0B
  • IPO Year
  • COHU N/A
  • MLYS 2023
  • Fundamental
  • Price
  • COHU $20.43
  • MLYS $14.80
  • Analyst Decision
  • COHU Buy
  • MLYS Strong Buy
  • Analyst Count
  • COHU 7
  • MLYS 4
  • Target Price
  • COHU $29.50
  • MLYS $27.00
  • AVG Volume (30 Days)
  • COHU 278.3K
  • MLYS 903.4K
  • Earning Date
  • COHU 07-30-2025
  • MLYS 08-12-2025
  • Dividend Yield
  • COHU N/A
  • MLYS N/A
  • EPS Growth
  • COHU N/A
  • MLYS N/A
  • EPS
  • COHU N/A
  • MLYS N/A
  • Revenue
  • COHU $390,962,000.00
  • MLYS N/A
  • Revenue This Year
  • COHU $10.84
  • MLYS N/A
  • Revenue Next Year
  • COHU $14.84
  • MLYS N/A
  • P/E Ratio
  • COHU N/A
  • MLYS N/A
  • Revenue Growth
  • COHU N/A
  • MLYS N/A
  • 52 Week Low
  • COHU $12.57
  • MLYS $8.24
  • 52 Week High
  • COHU $36.60
  • MLYS $18.38
  • Technical
  • Relative Strength Index (RSI)
  • COHU 62.18
  • MLYS 53.41
  • Support Level
  • COHU $19.72
  • MLYS $13.44
  • Resistance Level
  • COHU $20.87
  • MLYS $14.70
  • Average True Range (ATR)
  • COHU 0.67
  • MLYS 0.67
  • MACD
  • COHU 0.05
  • MLYS 0.12
  • Stochastic Oscillator
  • COHU 81.69
  • MLYS 99.44

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: